Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports By Reuters
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
Source link
Similar Posts
EMX Royalty (CVE:EMX) Shares Up 1.5% – Should You Buy?
EMX Royalty (CVE:EMX) Trading 1.5% Higher – Should You Buy? Source link
Vantagepoint AI Market Outlook for January 12, 2026
Welcome to the Artificial Intelligence Outlook for Forex trading. VIDEO TRANSCRIPT Okay, hello everyone, and welcome back.My name is Greg Firman, and this is the VantagePoint AI Market Outlook for the week of January 12th, 2026. U.S. DOLLAR INDEX Now, to get started this week, we will begin where we always do—with that very important…
I’d Invest $12,000 in These 3 High-Yield Dividend ETFs for Passive Income
When the market gets choppy, it’s easy to feel uncertain about where to invest. But for Canadian investors who want stability and income, high-yield dividend exchange-traded funds (ETFs) can be a calm port in the storm. These investments don’t just offer long-term growth, but also pay you to stay invested. So let’s look at three…
RBI Slaps a Rs 2.86 Crore Penalty to UCO Bank – Equitypandit
August 31, 2024August 31, 2024 The UCO Bank said that they have been imposed a Rs 2.68 crore penalty from the Reserve Bank of India for contravention of certain provisions, which includes an opening of current accounts, frauds classifications, and interest rate on deposits. Moreover,…
SBI Life Q2 Results: Profit falls 6% YoY to Rs 495 crore, but net premium income jumps 23%
SBI Life on Friday reported a 6% decline in net profit to Rs 495 crore for the second quarter, down from Rs 529 crore in the same quarter last year. Meanwhile, net premium income rose 23% year-on-year (YoY) to Rs 24,848 crore. More to come… Add as a Reliable and Trusted News Source (You can…
